Immunotherapy has an immense and growing impact on medicine and society : vaccines against pandemics, monoclonal antibodies – the most successful class of drugs, breakthrough cures of cancer and autoimmune diseases, and new hopes to fight degenerative diseases.
​
As immunologists and serial entrepreneurs, we contributed, at our small individual scale, to this biopharmaceutical revolution driven by immunology. 
​
We now join forces at Remora Biotech to leverage our entrepreneurial experience and, thanks to our supporting investors, to scale-up our ability to nurture and develop innovative life-changing immunotherapies. 
​
With our growing team and network of academic partners, business-oriented scientists, patent experts, drug developers and finance professionals, we create, finance, and manage a portfolio of daughter companies from discovery to clinical proof-of-concept. We aim at maximizing their odds of success and their strategic value for pharma partners while keeping capital efficient. 
 
Investors keen to gain exposure to this high-growth and high-impact sector, under the leadership of seasoned entrepreneurs, may become a shareholder of Remora Biotech and co-invest in our daughter companies.

Biotechnology

Life Sciences

Pharmaceutical

Remora Biotech

Remora Biotech's headquarters in Lausanne, Switzerland

Jean-Marc Le Doussal

Marco Alessandrini

Mickaël Machicoane

Jean - Marc Le Doussal

Charles Woler

Richard Groenendijk

Michael Bavand

Remora Biotech

Org chart

Teams

Offices

Similar companies